MBX Biosciences, Inc Common Stock (MBX) had the lowest return in January 2025 by a mid-cap US stock, returning -46.8%.

ASSET	MONTH	% RETURN
MBX Biosciences, Inc Common Stock (MBX)	January 2025	-46.76%
Dyne Therapeutics (DYN)	January 2025	-40.43%
QMMM Holdings Limited Ordinary Shares (QMMM)	January 2025	-39.69%
Quantum Computing (QUBT)	January 2025	-37.81%
Kodiak Sciences (KOD)	January 2025	-35.61%
Aehr Test Systems (AEHR)	January 2025	-32.8%
Agilysys (AGYS)	January 2025	-32.07%
Oruka Therapeutics (ORKA)	January 2025	-32%
Establishment Labs (ESTA)	January 2025	-31.6%
SoundHound AI (SOUN)	January 2025	-30.89%
D-Wave Quantum Inc Common Stock (QBTS)	January 2025	-30.12%
Ondas (ONDS)	January 2025	-30%
Erasca (ERAS)	January 2025	-27.03%
CNX Resources (CNX)	January 2025	-26.61%
Signet Jewelers (SIG)	January 2025	-26.54%
Maase (MAAS)	January 2025	-25.46%
Regencell Bioscience (RGC)	January 2025	-25.21%
Mercury General (MCY)	January 2025	-25.03%
Xometry (XMTR)	January 2025	-23.23%
Crinetics Pharmaceuticals (CRNX)	January 2025	-22.35%
AMC Entertainment (AMC)	January 2025	-22.25%
New Oriental Education & Technology (EDU)	January 2025	-22.22%
Fluence Energy (FLNC)	January 2025	-21.2%
ELF Beauty (ELF)	January 2025	-21.12%
Abercrombie & Fitch (ANF)	January 2025	-20.83%

Mid-cap stocks are treated as having a market cap between $2B and $10B.